PFM Health Sciences’s Avantor AVTR Stock Holding History

PFM Health Sciences’s Portfolio AVTR Stock Details AVTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,343,309	Closed	-$34.3M	–	82
2024 Q1	$34.3M	Buy	1,343,309 +666,571	+98%	+$15.9M	1.61%	21
2023 Q4	$15.4M	Buy	+676,738	New	+$13.9M	0.93%	35
2023 Q2	–	Sell	-1,351,326	Closed	-$28.6M	–	85
2023 Q1	$28.6M	Sell	1,351,326 -256,286	-16%	-$5.84M	1.26%	35
2022 Q4	$33.9M	Sell	1,607,612 -472,045	-23%	-$9.77M	1.21%	36
2022 Q3	$40.8M	Hold	2,079,657	–	–	1.47%	28
2022 Q2	$64.7M	Hold	2,079,657	–	–	2.47%	12
2022 Q1	$70.3M	Hold	2,079,657	–	–	2.63%	12
2021 Q4	$87.6M	Hold	2,079,657	–	–	2.98%	7
2021 Q3	$85.1M	Hold	2,079,657	–	–	2.5%	12
2021 Q2	$73.8M	Sell	2,079,657 -150,000	-7%	-$4.85M	2.31%	13
2021 Q1	$64.5M	Buy	2,229,657 +155,398	+7%	+$4.49M	1.97%	15
2020 Q4	$58.4M	Buy	2,074,259 +804,189	+63%	+$20.7M	2.05%	11
2020 Q3	$28.6M	Buy	+1,270,070	New	+$26.4M	1.32%	26
2019 Q3	–	Sell	-999,873	Closed	-$19.1M	–	76
2019 Q2	$19.1M	Buy	+999,873	New	+$17.8M	0.36%	66

Other funds holding AVTR

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NMC

New Mountain Capital New York $139M AUM 26.45% 1-Year Est. Return

PFM Health Sciences's AVTR Position: Q2 2024 in Review

PFM Health Sciences sold out of Avantor (AVTR) in Q2 2024, closing a stake of 1,343,309 shares — an estimated $34.3M sold.

PFM Health Sciences first reported a position in AVTR in Q2 2019 and held it in 14 quarters. The position peaked at $87.6M in Q4 2021. 514 funds tracked by Wall St. Rank hold AVTR as of Q2 2024.

PFM Health Sciences reported no remaining Avantor position as of Q2 2024 after selling out during the quarter.
PFM Health Sciences sold 1,343,309 Avantor shares in Q2 2024, an estimated $34.3M.
PFM Health Sciences first reported a position in Avantor in Q2 2019 and held it in 14 quarters.
PFM Health Sciences's Avantor position peaked at $87.6M in Q4 2021.
514 funds tracked by Wall St. Rank held Avantor as of Q2 2024.

Based on PFM Health Sciences's 13F filing for Q2 2024, filed 14 Aug 2024.